ch-vacd-ch-vaccination-plan-immunizations-vs
type: ValueSet
node role: treeRoot
id:
  v: ch-vacd-ch-vaccination-plan-immunizations-vs
text:
  status:
    v: generated
  div:
    v: Generated Narrative: ValueSet ch-vacd-ch-vaccination-plan-immunizations-vs Include these codes as defined in http://snomed.info/sct version Not Stated (use latest from terminology server) Code Display 42284007 Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure) 76668005 Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure) 127787002 Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure) 243789007 Administration of vaccine product containing only Hepatitis A virus antigen (procedure) 16584000 Administration of vaccine product containing only Hepatitis B virus antigen (procedure) 86198006 Administration of vaccine product containing only Influenza virus antigen (procedure) 314759000 Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) 47435007 Administration of vaccine product containing only Measles morbillivirus antigen (procedure) 719596001 Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) 314417000 Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) 871874000 Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure) 50583002 Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure) 761841000 Administration of vaccine product containing only Human papillomavirus antigen (procedure) 39343008 Administration of vaccine product containing only Bordetella pertussis antigen (procedure) 1119368005 Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) 1119366009 Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3…
url:
  v: http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-ch-vaccination-plan-immunizations-vs
  l: ch-vacd-ch-vaccination-plan-immunizations-vs
version:
  v: 3.4.0
name:
  v: SwissVaccinationPlanImmunizations
title:
  v: CH VACD Swiss Vaccination Plan Immunizations
status:
  v: active
experimental:
  v: false
date:
  v: 2026-06-10T09:49:50+00:00
publisher:
  v: HL7 Switzerland
contact:
  name:
    v: HL7 Switzerland
  telecom:
    system:
      v: url
    value:
      v: https://www.hl7.ch/
contact:
  name:
    v: HL7 Switzerland
  telecom:
    system:
      v: url
    value:
      v: https://www.hl7.ch/
    use:
      v: work
description:
  v: Immunization procedures for recommendations according to the vaccination plan.
jurisdiction:
  coding:
    system:
      v: urn:iso:std:iso:3166
      l: 3166
    code:
      v: CH
copyright:
  v: CC0-1.0
compose:
  include:
    system:
      v: http://snomed.info/sct
      l: sct
    concept:
      code:
        v: 42284007
      display:
        v: Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure)
    concept:
      code:
        v: 76668005
      display:
        v: Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure)
    concept:
      code:
        v: 127787002
      display:
        v: Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure)
    concept:
      code:
        v: 243789007
      display:
        v: Administration of vaccine product containing only Hepatitis A virus antigen (procedure)
    concept:
      code:
        v: 16584000
      display:
        v: Administration of vaccine product containing only Hepatitis B virus antigen (procedure)
    concept:
      code:
        v: 86198006
      display:
        v: Administration of vaccine product containing only Influenza virus antigen (procedure)
    concept:
      code:
        v: 314759000
      display:
        v: Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure)
    concept:
      code:
        v: 47435007
      display:
        v: Administration of vaccine product containing only Measles morbillivirus antigen (procedure)
    concept:
      code:
        v: 719596001
      display:
        v: Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure)
    concept:
      code:
        v: 314417000
      display:
        v: Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure)
    concept:
      code:
        v: 871874000
      display:
        v: Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure)
    concept:
      code:
        v: 50583002
      display:
        v: Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure)
    concept:
      code:
        v: 761841000
      display:
        v: Administration of vaccine product containing only Human papillomavirus antigen (procedure)
    concept:
      code:
        v: 39343008
      display:
        v: Administration of vaccine product containing only Bordetella pertussis antigen (procedure)
    concept:
      code:
        v: 1119368005
      display:
        v: Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure)
    concept:
      code:
        v: 1119366009
      display:
        v: Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure)
    concept:
      code:
        v: 1119367000
      display:
        v: Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure)
    concept:
      code:
        v: 72093006
      display:
        v: Administration of vaccine product containing only Human poliovirus antigen (procedure)
    concept:
      code:
        v: 34631000
      display:
        v: Administration of vaccine product containing only Rabies lyssavirus antigen (procedure)
    concept:
      code:
        v: 82314000
      display:
        v: Administration of vaccine product containing only Rubella virus antigen (procedure)
    concept:
      code:
        v: 127786006
      display:
        v: Administration of vaccine product containing only Clostridium tetani antigen (procedure)
    concept:
      code:
        v: 281658005
      display:
        v: Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure)
    concept:
      code:
        v: 15483003
      display:
        v: Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure)
    concept:
      code:
        v: 737081007
      display:
        v: Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure)
    concept:
      code:
        v: 722215002
      display:
        v: Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure)
    concept:
      code:
        v: 67308009
      display:
        v: Administration of vaccine product containing only Yellow fever virus antigen (procedure)
    concept:
      code:
        v: 1157107003
      display:
        v: Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure)
    concept:
      code:
        v: 1119350007
      display:
        v: Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
    concept:
      code:
        v: 1209198003

v: Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure)

code:
  v: 1162645008
display:
  v: Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure)